Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity

Source: NEJM

Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers – The EAGLES Trial

Source: JAMA Internal Medicine, Visualmed

Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality

Source: NEJM

Undetectable high sensitivity cardiac troponin T level in ED and risk of MI

Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine – the PRESERVE Trial

Source: NEJM

Fibrinolysis for patients with intermediate-risk pulmonary embolism – The PEITHO Trial

Source: NEJM

Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis – The PRECISION Trial

Source: NEJM

Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the MASS trial

Source: BMJ

N-Terminal Pro–B-Type Natriuretic Peptide in the Emergency Department – The ICON-RELOADED Study

Source: JACC

Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease – The PROMISE Trial

Source: NEJM

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes – The CANVAS Trial

Source: NEJM

Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab – ODYSSEY Outcomes Trial

Vest Prevention of Early Death Trial – VEST Trial

A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops